Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-010845
Filing Date
2022-10-27
Accepted
2022-10-27 17:01:31
Documents
2
Period of Report
2022-10-17

Document Format Files

Seq Description Document Type Size
1 form3-10272022_021015.html 3  
1 form3-10272022_021015.xml 3 7154
2 ex24-10272022_021015.htm EX-24 4127
  Complete submission text file 0001415889-22-010845.txt   12578
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Siatis Perry C (Reporting) CIK: 0001951400 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 221337998